Thoughts on Audinate and Capital Health please?

Debbie,

Two very different companies here hence we’ve briefly updated our view on both:

1. Audinate Group (AD8) $7.81 – we visited this software developer in December hearing from their international technology teams who were out visiting their offices in Surry Hills. We believe this is a good company, with good people running it, a great product that has dominance in one area (audio). We maintain our bullish stance towards AD8 and see this as a medium to longer-term opportunity within our Emerging Companies Portfolio – we believe the stocks good value under $8. Last weeks decline was a result of issues from the chip makers, with some chips now in oversupply but some remain hard to get. This has been an ongoing issue for companies like Audinate over recent years.
2. Capitol Health (CAJ) 28.5c – the diagnostic imagining business has just endured a tough week, falling over 10% in a strong market. Like you, we are losing patience with this position and will certainly use it as a funding vehicle if other (better) opportunities emerge.  The weakness seems to be flow related for a stocks that has fairly low liquidity. They report 1H23 results on Feb 23.

chart

Audinate (AD8)

LAST UPDATED 03/02/2023 15:06

Close

chart

Audinate (AD8)

LAST UPDATED 03/02/2023 15:06